[HTML][HTML] Conserved brain myelination networks are altered in Alzheimer's and other neurodegenerative diseases

M Allen, X Wang, JD Burgess, J Watzlawik… - Alzheimer's & …, 2018 - Elsevier
Introduction Comparative transcriptome analyses in Alzheimer's disease (AD) and other
neurodegenerative proteinopathies can uncover both shared and distinct disease pathways …

Systematic tissue-specific functional annotation of the human genome highlights immune-related DNA elements for late-onset Alzheimer's disease

Q Lu, RL Powles, S Abdallah, D Ou, Q Wang, Y Hu… - PLoS …, 2017 - journals.plos.org
Continuing efforts from large international consortia have made genome-wide epigenomic
and transcriptomic annotation data publicly available for a variety of cell and tissue types …

Towards understanding brain-gut-microbiome connections in Alzheimer's disease

R Xu, QQ Wang - BMC systems biology, 2016 - Springer
Background Alzheimer's disease (AD) is complex, with genetic, epigenetic, and
environmental factors contributing to disease susceptibility and progression. While …

[HTML][HTML] Tau, amyloid, and cascading network failure across the Alzheimer's disease spectrum

DT Jones, J Graff-Radford, VJ Lowe, HJ Wiste… - Cortex, 2017 - Elsevier
Functionally related brain regions are selectively vulnerable to Alzheimer's disease
pathophysiology. However, molecular markers of this pathophysiology (ie, beta-amyloid and …

Transcriptomics profiling of Alzheimer's disease reveal neurovascular defects, altered amyloid-β homeostasis, and deregulated expression of long noncoding RNAs

M Magistri, D Velmeshev… - Journal of …, 2015 - content.iospress.com
The underlying genetic variations of late-onset Alzheimer's disease (LOAD) cases remain
largely unknown. A combination of genetic variations with variable penetrance and lifetime …

Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia

V Swarup, FI Hinz, JE Rexach, K Noguchi… - Nature medicine, 2019 - nature.com
Identifying the mechanisms through which genetic risk causes dementia is an imperative for
new therapeutic development. Here, we apply a multistage, systems biology approach to …

[HTML][HTML] Meta-analysis of the Alzheimer's disease human brain transcriptome and functional dissection in mouse models

YW Wan, R Al-Ouran, CG Mangleburg, TM Perumal… - Cell reports, 2020 - cell.com
We present a consensus atlas of the human brain transcriptome in Alzheimer's disease
(AD), based on meta-analysis of differential gene expression in 2,114 postmortem samples …

Dissecting complex and multifactorial nature of Alzheimer's disease pathogenesis: a clinical, genomic, and systems biology perspective

P Talwar, J Sinha, S Grover, C Rawat… - Molecular …, 2016 - Springer
Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by loss
of memory and other cognitive functions. AD can be classified into familial AD (FAD) and …

Interactome mapping suggests new mechanistic details underlying Alzheimer's disease

M Soler-López, A Zanzoni, R Lluís, U Stelzl… - Genome …, 2011 - genome.cshlp.org
Recent advances toward the characterization of Alzheimer's disease (AD) have permitted
the identification of a dozen of genetic risk factors, although many more remain …

Molecular insights into the pathogenesis of Alzheimer's disease and its relationship to normal aging

AA Podtelezhnikov, KQ Tanis, M Nebozhyn, WJ Ray… - PloS one, 2011 - journals.plos.org
Alzheimer's disease (AD) is a complex neurodegenerative disorder that diverges from the
process of normal brain aging by unknown mechanisms. We analyzed the global structure of …